CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324725
- Phone
- 833 275 2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- 4 Open-market buy Director bought 5,664 shares at $3.18 ($18,012)
- 4 Open-market buy Director bought 2,500 shares at $3.10 ($7,750)
- 4 Open-market buy Chief Executive Officer bought 6,289 shares at $3.18 ($19,999)
- 4 Open-market buy Director bought 1,562 shares at $3.30 ($5,155)
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- 8-A12B Other Registration of Securities
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Open-market buy Chief Executive Officer bought 10 shares at $6.20 ($62)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 2 of 14 · 276 filings